To date, we have donated over $172,000 for a comparative oncology study of mammary tumors at Princeton University in collaboration with the University of Pennsylvania. The project treats shelter dogs with mammary tumors and then studies the tissues to understand how breast cancer metastasizes in women.
We have also contributed $40,000 to MIT and Harvard’s Broad Institute for studies on osteosarcoma (bone cancer) and Mast Cell Tumors. A grant of $80,000 was given to the Animal Medical Center of New York and Memorial Sloan Kettering to study transitional cell carcinoma (TCC). This is the most common type of bladder cancer diagnosed by veterinarians, and a difficult one to treat.
We have funded a study in osteosarcoma with the University of Wisconsin, and one with the University of Texas MD Anderson Center who is developing an immunotherapy approach to canine osteosarcoma by using a dog's NK or Natural Killer lymphocytes to attack spontaneous bone cancer cells. Each of these studies will span two years and together total $ 196,000.
Most recently, $100,000 has been granted to Purdue University in order to improve molecularly-targeted cancer therapy in pet dogs and humans.
1.) Broadening our understanding of the links between human and companion animal cancer,
2.) developing new approaches to research,
3.) and funding translational cancer studies that benefit both pets and people.